Table 2.
Prognostic factors for overall survival identified by univariate and multivariate analyses (n = 100)
| Variables | n (%) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
| p value | HR | 95% CI | p value | ||
| Age | |||||
| <66 years | 50 (50.0) | 0.002 | 1 | 0.090 | |
| ≥66 years | 50 (50.0) | 2.026 | 0.899–4.939 | ||
| Sex | |||||
| Male | 67 (67.0) | 0.376 | |||
| Female | 33 (33.0) | ||||
| Procedure | |||||
| Sp + Dev | 45 (45.0) | 0.005 | 1 | 0.730 | |
| BRTO | 55 (55.0) | 1.253 | 0.361–4.798 | ||
| Serology of viral hepatitis | |||||
| HBV or HBC | 55 (55.0) | 0.732 | |||
| Non-B and non-C | 45 (45.0) | ||||
| Concurrent HCC | |||||
| Yes | 44 (44.0) | 0.289 | |||
| No | 56 (56.0) | ||||
| White blood cell counts | |||||
| ≥3240 (mm3) | 57 (57.0) | 1 | 0.642 | ||
| <3240 (mm3) | 43 (43.0) | 0.036 | 1.303 | 0.441–4.249 | |
| Hemoglobin | |||||
| ≥10.7 (g / dL) | 57 (57.0) | 1 | 0.945 | ||
| <10.7 (g / dL) | 43 (43.0) | 0.002 | 1.038 | 0.342–2.910 | |
| Platelet counts | |||||
| <6.6 (×104/mm3) | 33 (33.0) | 0.020 | 1 | 0.156 | |
| ≥6.6 (×104/mm3) | 67 (67.0) | 2.438 | 0.726–9.737 | ||
| Total bilirubin | |||||
| <0.8 (mg/dL) | 79 (79.0) | 0.100 | |||
| ≥0.8 (mg/dL) | 21 (21.0) | ||||
| Aspartate aminotransferase | |||||
| <43 (IU/L) | 65 (65.0) | 0.005 | 1 | 0.983 | |
| ≥43 (IU/L) | 35 (35.0) | 1.010 | 0.417–2.544 | ||
| Alanine aminotransferase | |||||
| <29 (IU/L) | 57 (57.0) | 0.091 | 1 | 0.101 | |
| ≥29 (IU/L) | 43 (43.0) | 2.382 | 0.844–6.725 | ||
| Albumin | |||||
| >3.6 (g/dL) | 37 (37.0) | 0.001 | 1 | 0.042 | |
| ≤3.6 (g/dL) | 63 (63.0) | 4.099 | 1.049–19.036 | ||
| Prothrombin time% activity | |||||
| >80 (%) | 19 (19.0) | 0.045 | 1 | 0.039 | |
| ≤80 (%) | 81 (81.0) | 4.324 | 1.070–29.699 | ||
| Creatinine | |||||
| <0.84 (mg/dL) | 64 (64.0) | 0.013 | 1 | ||
| ≥0.84 (mg/dL) | 36 (36.0) | 3.229 | 1.524–6.967 | 0.002 | |
HR hazard ratio, CI confidential interval, HCC hepatocellular carcinoma, Sp + Dev splenectomy and gastric devascularization, BRTO balloon-occluded transvenous retrograde obliteration, HBV hepatitis B virus, HCV hepatitis C virus